Home › Trials › NCT05907265
Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using virtual reality to improve cognition in cancer patients

Official title: Study of the Benefits of Immersive Virtual Reality Techniques on the Effects on Cognition in People With Cancer (OncoBRAIN)

Run by Consorci Sanitari de Terrassa · NCT05907265 · Data updated 2026-11-12

This study is testing whether using virtual reality exercises can help cancer patients improve their thinking skills and feel better during chemotherapy.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorConsorci Sanitari de Terrassa
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Terrassa)
StatusRecruiting
StartedMay 1, 2023
Main results expectedDecember 30, 2026
Study endsJune 30, 2027
Registry record updatedApril 17, 2026
Trial IDNCT05907265 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 who have been diagnosed with cancer and have experienced cognitive complaints following chemotherapy.

Probably not a fit

Patients currently undergoing chemotherapy or those with pre-existing psychiatric or neurological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

OncoBRAIN evaluates the impact of an immersive virtual reality intervention designed to enhance cognitive function, emotional well-being, and quality of life in individuals diagnosed with cancer and experiencing chemotherapy-related cognitive deficits. Participants will engage in cognitive, physical activity, and mindfulness exercises through virtual reality. The study aims to compare the cognitive performance and emotional state of those receiving the intervention against a control group not receiving it. The hypothesis is that the experimental group will show significant improvements in cognitive abilities such as memory and attention, as well as overall quality of life.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance cognitive function and emotional well-being in cancer patients suffering from cognitive deficits.

How similar studies have gone: While immersive virtual reality is a novel approach in this context, similar interventions have shown promise in improving cognitive function in other populations.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

A. Over 18 years of age and under 65 years of age B. Diagnosis of cancer C. At least 4 weeks since the last chemotherapy treatment session D. Presence of cognitive complaints after chemotherapy treatment E. Level of primary education to be able to perform the cognitive tests. F. Consent to participate in the study

Exclusion Criteria:

A. Established diagnosis prior to cancer diagnosis of psychiatric, neurological, neurodevelopmental or systemic disorder causing cognitive deficits.

B. Motor or sensory impairments that preclude completion of the program. C. Undergoing chemotherapy treatment

Where it's running

  • Consorci Sanitari de Terrassa
    Terrassa, Spain     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Cognitive Impairment 479Consorci Sanitari de Terrassa 9
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.